Materials and Methods
Mice . Two Igh-congenic strains were used : C .B-17 (Igh b ) and BALB/cAnNIcr (Igh°) . C .B-17 refers to BALB/cIcr mice that carry the Igh gene complex of C57BL/Ka (Ighb ) . C57BL/ 6JNIcr, C .B-17, and C57BL/Ka are not known to differ with respect to the Ighb complex . All mice were bred and maintained at the Institute for Cancer Research .
Cell Lines. The cell lines used in this study are listed in Table I . CB101, B79, and U10 were derived from plasmacytomas generously supplied by Dr . Michael Potter (National Cancer Institute, Bethesda, Md .) . CB101NP is a variant cell line of CB101 that no longer synthesizes detectable Igh-l b heavy chains. The Igh-l b -producing hybridomas, 540A6 and R3-367, were derived from the fusion of a BALB/c myeloma (P3 X 63Ag8) with C57BL/6 spleen cells and were gifts from Dr. Barbara Knowles (The Wistar Institute, Philadelphia, Pa .) and Dr . Theresa Imanishi-Karl (Massachusetts Institute for Technology, Boston, Mass.), respectively . S10P is an Igh-4b-producing hybridoma obtained by the fusion of SP2 (16) with C .B-17 spleen cells according to the technique of Kennett et al . (17) . All cell lines were maintained in vitro and periodically recloned to maintain a homogeneous phenotype .
Purification of Igh-1 b Proteins. The Ig proteins in ascites fluids of mice bearing the Igh-l bproducing plasmacytomas, CBPC101 and BEPC79, were precipitated with (NH4)2SO4 (45% vol :vol), redissolved in 0 .2 M NaCl, and dialyzed extensively against 10 mM NaCl . The resulting euglobulin precipitate was redissolved in 0 .5 M NaCl, 100 mM Tris, pH 8, and subjected to gel filtration over a column of Biogel A0 .5 (Bio-Rad Laboratories, Richmond, Calif.) equilibrated with the same buffer . The ascending limb of the 7S peak was collected and concentrated by vacuum dialysis against 150 mM NaCl, 10 mM Tris, pH 8 . Purified Igh-1 a,
Igh-4 8 , and Igh-4b myeloma proteins were obtained by similar techniques.
R3-367, an Igh-l b protein that binds (3-nitro-4-hydroxyphenyl)acetyl (NP),' was specifically purified over NP-affinity columns . These columns were prepared by first substituting Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, N. J.) with amino groups by resuspending CNBractivated Sepharose in ethylenediamine (25% vol :vol, pH 9) . NP was subsequently attached by an overnight incubation at 25°C of the amino-substituted Sepharose (50% vol :vol in 3% NaHC03, pH 8 .5) with an equal volume of dioxane containing NP-cap-succinimide (2 .5 mg/ ml ; Biosearch, San Rafael, Calif) (18) . Ascites fluids from mice bearing R3-367 tumors were allowed to clot, clarified by centrifugation, and then mixed with an equal volume of Alsever's solution and passed through an NP column . The column was washed with phosphate-buffered saline (PBS) until the eluate OD was <0 .005 . The anti-NP antibodies were then eluted with 5 X 10-4 M (3-nitro-4-hydroxy-5-iodophenyl)acetyl-cap, and dialysed extensively against PBS . The purity of these preparations was monitored by sodium dodecyl sulfate-polyacrylamide gel electrophoresis .
Immunizations. Immunization of BALB/c mice against purified Igh-l b proteins of different tumors (CBPC101, BEPC79, and R3-367) consisted of multiple intraperitoneal injections of 100 jig of Igh-l b. The first injection was in complete Freund's adjuvant, the second was in incomplete adjuvant, and subsequent injections were in buffered saline . Hyperimmunization of BALB/c mice with C57BL/6 serum was done in the manner described earlier (19) .
Igh-1 b Suppression. The ability of immune T cells to induce Igh-l b suppression in vivo was assessed by a protocol described elsewhere (7) . Briefly, immune BALB/c T cells (2 X 106 ) and C .B-17 spleen cells (2 X 106 ) were cotransferred (intravenously) into sublethally irradiated (550 rad) BALB/c recipients. Recipient sera were tested in Ouchterlony assays for production of Igh-l b .
Rosetting of Ig-binding T Cells . Purified myeloma proteins or salt fractionated goat-anti-mouse Ig (GAMIg) were coupled to sheep erythrocytes (SRBC) by means of CrC13 according to the procedure of Goding (20) . Briefly, 1 ml of CrC13 (0 .01% wt :vol in saline) was slowly added to a 3-ml vortexing solution of SRBC (33% vol :vol) and Ig (0.3 mg/ml) . The mixture was allowed to stand for 10 min at 25°C and washed twice with PBS .
Rosette-forming T cells were prepared and purified as described by Parish and McKenzie (21) . Nylon wool-purified T cells were spun down with a 100-fold excess of SRBC, allowed to Tumor Cell Lines stand 60 min at 25°C, and gently resuspended in 1 ml Hanks' balanced salt solution (HBSS) . The cell suspension was layered over a solution of Ficoll (5.6%)/Isopaque (9.6%) and spun at 2,000 g for 15 min at 25°C . The cell pellet was washed twice with HBSS, and the SRBC were lysed with NH4C1 (22) .
Generation of Cytotoxic T (Tc) Cells. Single cell suspensions were prepared from spleens of immunized mice and the erythrocytes were lysed by treatment with NH 4 C1 . 5 X 10 6 spleen cells were cultured with 1 X 105 -10 X 105 irradiated (2,000 rad) CB101 cells in a total volume of 2 ml in Linbro tissue culture dishes (Flow Laboratories, Hamden, Conn .) . The culture medium consisted of RPMI-1640 (Microbiological Associates, Walkersville, Md .), 10% fetal calf serum, 5 X 10 -5 M 2-mercaptoethanol, 501ag/ml gentamycin (Schering Corp ., Kenilworth, N . J .), and 2 mM glutamine. Cultures were incubated at 37°C in a humidified incubator for 5-6 d .
Cytotoxicity Assay . After 5-6 d in culture, the effector cells were harvested and tested in a standard 5 'Cr release assay (23) . In the majority of experiments, the spontaneous release values were <20% of the maximum release, which was determined by detergent lysis . Experiments in which the spontaneous release was >35% were discarded . All results are reported as percent specific lysis, which is calculated as 100 X (EXP -spontaneous release)/ (maximum releasespontaneous release), where EXP equals the counts per minute of chromium released in the presence of effector cells . All values represent the mean of quadruplicate measurements . In all cases, the standard errors were <5% and therefore they are not given .
Antiserum and Complement Treatments. Anti-Thy-1 .2 was prepared in AKR/J mice by multiple immunizations with C3H/J thymocytes . For T cell depletion, 0 .2 ml of this antiserum was added to 2 .5 X 10 7 cells. After 30 min on ice, the cells were washed twice and resuspended in 2 ml guinea pig serum (1 :7 dilution), as a source of complement, and incubated for 45 min at 37°C . Under these conditions, >95% of thymocyte and <5% of bone marrow cells are killed . (Table II) demonstrate that all the mice receiving T cells rosetted with Igh-l b were suppressed for Igh-l b production at 4 wk (groups A and E), whereas only one out of five recipients was suppressed in the control groups (groups B-D, F, and G) . These findings indicate that some allotype Spleen cells from Igb-immune BALB/c mice were restimulated in vitro with an irradiated Igh-l b-producing myeloma, CB101, and then tested for cytolytic activity against radiolabeled CB101 cells . Fig. 1 illustrates the mean cytolytic activity from eight such experiments . These experiments demonstrate that both in vivo priming and in vitro restimulation are required to generate detectable cytolytic activity . Importantly, CB101NP, a non-Ig-producing variant of CB101, does not effectively restimulate Tc cell activity .
The cells responsible for the cytolytic effect are T cells ; this is demonstrated by the observation that prior treatment of these killer cell populations with anti-Thy-1 .2 and complement abrogates their lytic ability (Table III) .
Specificity of the Tc Cells.
The functional specificity of cytolytic T cells, which were primed in vivo with C57BL/6 immune serum and restimulated in vitro with CB101 myeloma cells, was assessed by comparing their lytic potency on a variety of different cell lines . The results show that only Igh-l b -producing cell lines are lysed (Fig. 2) . Targets that were not lysed included the non-Ig-producing variant of CB 101 (CB101NP), an Igh-l a-producing myeloma (U10), an Igh-4 b -producing BALB/c X C.B-17 hybridoma (S10P), as well as C.B-17 mitogen-induced (lipopolysaccharide and concanavalin A) blast cells.
These data suggest that Tc cells generated in this fashion are specific for determinants of the Igh-l b allotype . The experiments presented in Table IV support this suggestion by demonstrating that purified Igh-lb can serve as the priming immunogen . Chromatographically purified Igh-l b myeloma proteins (CB101 and B79) and an affinity-purified Igh-l b hybridoma protein (R3-367) all efficiently prime the BALB/c Tc cell response (Table IV) . Fig . 3 demonstrates that BALB/c anti-Igh-lb Tc display an apparent major histocompatibility complex restriction ; they lyse Igh-l b-producing targets of the Experiment Effectors were generated as described in Materials and Methods from spleen cells of mice that had been immunized in vivo with C57BL/6 serum, and restimulated in vitro with CB101 myeloma cells. Before treatment, the effector : target ratio was 40 :1 and no adjustment was made in cell numbers after the various treatments . Earlier studies in mice have shown that chronic suppression of Igh-l b production is mediated by T cells (5, 7). These studies concluded that the target of Ts was a helper T cell population, and from this it seems unlikely that the specificity of Ts would be directed to an Ig allotype .
To investigate this point, the specificity of a Ts cell population capable of regulating allotype expression was examined by using rosetting procedures. Table II (24) (25) (26) (27) (28) ; therefore the finding that allotype Ts cells bind Igh-l b is not without precedent .
It is of interest that the nonrosetted immune BALB/c spleen cell population was also capable of Igh-l b suppression in vivo (unpublished results) . This could result either from a technical shortcoming, i.e., that rosetting was incomplete, or alternatively, immune spleen cell populations may contain allotype suppressor T cells with specificity directed to determinants other than the Igh-l b allotype itself.
The most straightforward interpretation of the results of the Igh-l" rosetting experiments is that Ts exist having surface receptors specific for Igh-l b and that interaction of these cells with target Igh-l b B cells results in their suppression or elimination . This interpretation is supported by the demonstration in earlier studies that Igh-l b myelomas fail to grow in allotype-suppressed hosts (13) .
Specificity of Tc Cells from Igh-lb-immune BALB/c Mice.
The studies described here also show that priming BALB/c mice with C57BL immune serum in vivo and restimulation with Igh-l b myeloma in vitro induces cytotoxic T cells that lyse Igh-l bproducing myelomas (Figs. 1 and 2 ) . Several findings support the conclusion that these Tc cells' are specific for allotypic determinants present on the Igh-l b molecule : (a) in vivo priming is required for generating cytotoxic cells and this can be accomplished with purified Igh-lb myeloma proteins (Table IV) ; (b) restimulation in vitro is also required and only Igh-l b -producing myelomas are effective stimulators ; a nonproducing variant is not effective (Fig. 1) ; (c) once stimulated, these cytotoxic cells are lytic only for Igh-l b -producing target cells. Target cells not lysed include Igh-1 a-and Igh-4 b -producing cell lines as well as an Ig-non-producing variant of CB101, CB101NP (Fig. 2) , which does not secrete or produce any detectable Igh-l" (unpublished results) ; and (d) idiotypes are apparently not involved because two independent Igh-l b-producing cells can serve as targets (Fig. 2) and three different myeloma proteins can serve as priming immunogens for this Tc response (Table IV) . Tumor-specific antigens in these experiments can be ruled out by the observation that affinity-purified Ig can serve as the priming immunogen (Table IV) , and by the finding that CB 101NP is not lysed (Fig . 2) . The involvement of allotype-linked minor histocompatibility differences between BALB/c and C .B-17 mice (29-31) can also be excluded . These antigens are expressed on mitogen-induced blasts, and would also be expected to be present on an Igh-4b-producing hybridoma cell line that is partly of C .B-17 origin . Nevertheless, these particular target cells are not lysed by allotypeprimed killer cells (Fig . 2) .
The strongest evidence supporting the conclusion that these Tc are specific for allotypic determinants of the Igh-l b molecule is presented in the accompanying paper (32) . Tc cells cloned from bulk populations similar to those described in Fig. 2 display functional specificity identical with the bulk populations . Incubation of these cloned Tc cells with affinity-purified Igh-l b results in a marked and specific reduction of the cytotoxic ability of these cells .
Another important aspect of killer cell specificity is that controlled by gene products of the major histocompatibility complex. Preliminary results indicate that allotypespecific cytotoxic populations are restricted to the BALB/c (H-2 d) haplotype . These studies are limited, however, because target cell lines expressing Igh-l b and major histocompatibility complex haplotypes other than H-2d are not available .
Involvement of Tc Cells in Allotype Suppression . Because both T cell effector functions, suppression and cytotoxicity, seem to be mediated by T cells of like specificity for determinants of the Igh-l b molecule, the question arises whether both functions are mediated by the same T cell . The present studies indicate that at the level of bulk populations of effector cells, these two functions cannot be separated . Both can be induced by priming with purified Igh-l b proteins and both show specificity for Igh-l b proteins, one by rosetting and the other by cytotoxicity . Moreover, as described in the accompanying paper, a cytotoxic Igh-lb-specific T cell line is able to suppress expression of Igh-l b in vivo (32) . We therefore feel that the possibility remains that allotype-specific Tc could have a physiologic role in the regulation of allotype suppression .
Another precedent for the suggestion that Tc may regulate expression of Ig in vivo is the demonstration of Segal et al. (33) that T cells from high zone tolerant mice could kill macrophages pulsed with the tolerizing antigen . However, Abbas et al. (34) (35) (36) have shown recently that suppression and cytotoxicity may operate by quite different mechanisms at the level of the target cell . Tc directed against one of the Ig proteins of a double producing hyridoma caused the cessation of synthesis of both Ig proteins and target cell lysis, but when exposed to Ts cells specific for one of the Ig proteins, synthesis of only the specific protein was suppressed in the double producing hybridoma.
The premise that B cells are the direct target of Ts cells in chronic allotype suppression stands in apparent contrast to mechanisms suggested by Herzenberg et al. (14) . In this model, Ts cells are thought to eliminate Igh-l b-specific Th cells and thereby to influence Igh-l b production indirectly. The target determinants of helper T cells that provide the basis for discrimination by Ts cells have not been identified . In our view, these mechanisms are not necessarily mutually exclusive ; both could be operative to varying degrees . Consistent with this suggestion is the recent observation, using the neonatal suppression system where helper T cells are thought to be the target of Ts cells, of the existence of Ts cells that inhibit both T-independent Igh-l b production (37) and the growth of an Igh-l b myeloma (38) .
It remains unclear in the neonatal suppression system how administration of antiallotype antibody induces allotype-specific Ts cells . One possibility that could be considered is that the temporary elimination of allotype-producing B cell subpopulations by anti-allotype antibody results in the consequent lack of tolerance in the T cell compartment to Ig allotyppc determinants . The later emergence of allotypepositive B cells could then induce activation of allotype-specific T suppressor and/or killer cells. Similarly, in the absence of allotype-positive B cells, one might expect alterations in the expressed repertoire of T cells having specificity for allotype (39) .
Summary
We show that determinants of IgG2a of C57BL/6 mice (Igh-l b) stimulate allotypespecific T cells in BALB/c mice. Such cells are detected in two different functional assays ; chronic allotype suppression and T cell-mediated cytotoxicity . A population of suppressor T cells capable of inducing chronic Igh-l b suppression was demonstrated by rosetting procedures to possess Igh-l b-specific receptors, a result interpreted as indicating that suppressor T cells may act directly upon allotype-bearing B cells . From similar populations we were also able to demonstrate Igh-l b-specific cytotoxic T cells. Such cells were lytic for target myeloma cells expressing the Igh-l b allotype of IgG28, and were ineffective against a variant cell line failing to express Igh-l b, and other target cell lines expressing different allotypes or isotypes. The similar specificity of suppressor T cells and cytotoxic T lymphocytes for Igh-l b allotype raises the possibility that the target in allotype suppression is a B cell, and that allotype-specific cytotoxic T cells may play some role in regulation of allotype expression in the suppressed state.
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